{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:57:42Z","timestamp":1794121062418,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72204071"],"award-info":[{"award-number":["72204071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Foundation for Scholars of HZNU","award":["4265C50221204119"],"award-info":[{"award-number":["4265C50221204119"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The effects of insulin-like growth factor-1 (IGF-1) deficiency on cognitive decline have been consistently reported in animal studies, but the relationship between IGF-1 and human brain health remains controversial. Our study aimed to investigate the associations of serum IGF-1 concentrations with some brain-related disorders and neuroimaging features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective study included 369,711 participants (55.8\u2009\u00b1\u20098.1\u00a0years) from the UK biobank who had serum IGF-1 measured and were free from brain-related disorders of interest \u2014 dementia, stroke, and Parkinson\u2019s disease (PD) \u2014 at enrollment (2006\u20132010). Restricted cubic splines and Cox proportional hazards models were used to detect the associations between IGF-1 concentrations and brain-related diseases. In addition, general linear regressions were applied to explore the relationship between IGF-1 concentrations and neuroimaging features (volumes of white matter, grey matter, and hippocampus and white matter hyperintensity) among a sub-sample of 36,458 participants with magnetic resonance imaging data collected since 2014.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During a median follow-up of 12.6\u00a0years, a total of 4,857 dementia, 6,240 stroke, and 2,116 PD cases were documented. The dose\u2013response analyses yielded U-shaped relationships between IGF-1 concentrations and risks of dementia and stroke (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001 for non-linearity), with the lowest risks at 18\u00a0nmol\/L and 26\u00a0nmol\/L, respectively. A positive linear relationship was observed between IGF-1 concentrations and risk of PD (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.163 for non-linearity). Moreover, neuroimaging analyses showed that higher IGF-1 concentrations were associated with greater volumes of white matter (\u03b2\u2009=\u20092.98\u2009\u00d7\u200910\n                      <jats:sup>\u20134<\/jats:sup>\n                      ,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and hippocampus (\u03b2\u2009=\u20093.37\u2009\u00d7\u200910\n                      <jats:sup>\u20134<\/jats:sup>\n                      ,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) and smaller white matter hyperintensity (\u03b2\u2009=\u2009-3.12\u2009\u00d7\u200910\n                      <jats:sup>\u20133<\/jats:sup>\n                      ,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Apart from the diverse associations with neuroimaging features, both low and high IGF-1 concentrations are associated with increased risks of dementia and stroke and higher IGF-1 concentrations are linked to a higher risk of PD, highlighting the potential of IGF-1 as a biomarker for risk stratification of brain health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-023-01288-5","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T06:02:31Z","timestamp":1692684151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Circulating insulin-like growth factor-1 and brain health: Evidence from 369,711 participants in the UK Biobank"],"prefix":"10.1186","volume":"15","author":[{"given":"Zhi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyi","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"1288_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","volume":"325","author":"AH Dyer","year":"2016","unstructured":"Dyer AH, Vahdatpour C, Sanfeliu A, Tropea D. The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience. 2016;325:89\u201399.","journal-title":"Neuroscience"},{"issue":"12","key":"1288_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12):915\u201328.","journal-title":"Nat Rev Cancer"},{"issue":"9319","key":"1288_CR3","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/S0140-6736(02)08655-5","volume":"359","author":"MS Sandhu","year":"2002","unstructured":"Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet. 2002;359(9319):1740\u20135.","journal-title":"Lancet"},{"issue":"8","key":"1288_CR4","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1210\/endo.138.8.5330","volume":"138","author":"WE Sonntag","year":"1997","unstructured":"Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology. 1997;138(8):3515\u201320.","journal-title":"Endocrinology"},{"issue":"1\u20133","key":"1288_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.02.047","volume":"490","author":"PS van Dam","year":"2004","unstructured":"van Dam PS, Aleman A. Insulin-like growth factor-I, cognition and brain aging. Eur J Pharmacol. 2004;490(1\u20133):87\u201395.","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"1288_CR6","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.1073\/pnas.1817391116","volume":"116","author":"M Soto","year":"2019","unstructured":"Soto M, Cai W, Konishi M, Kahn CR. Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. Proc Natl Acad Sci U S A. 2019;116(13):6379\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1288_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0896-6273(93)90173-O","volume":"10","author":"MJ Carson","year":"1993","unstructured":"Carson MJ, Behringer RR, Brinster RL, McMorris FA. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 1993;10(4):729\u201340.","journal-title":"Neuron"},{"issue":"2","key":"1288_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.trsl.2009.05.001","volume":"154","author":"N Harada","year":"2009","unstructured":"Harada N, Narimatsu N, Kurihara H, Nakagata N, Okajima K. Stimulation of sensory neurons improves cognitive function by promoting the hippocampal production of insulin-like growth factor-I in mice. Transl Res. 2009;154(2):90\u2013102.","journal-title":"Transl Res"},{"issue":"12","key":"1288_CR9","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm1202-793","volume":"8","author":"E Carro","year":"2002","unstructured":"Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med. 2002;8(12):1390\u20137.","journal-title":"Nat Med"},{"key":"1288_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnins.2015.00204","volume":"9","author":"G Bedse","year":"2015","unstructured":"Bedse G, Di Domenico F, Serviddio G, Cassano T. Aberrant insulin signaling in Alzheimer\u2019s disease: current knowledge. Front Neurosci. 2015;9:204.","journal-title":"Front Neurosci"},{"issue":"3","key":"1288_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3233\/JAD-210516","volume":"82","author":"LZ Xu","year":"2021","unstructured":"Xu LZ, Li FY, Li BQ, Cao SM, Li Y, Xu J, Jia JP. Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer\u2019s Disease: A Meta-Analysis. J Alzheimers Dis. 2021;82(3):1357\u201367.","journal-title":"J Alzheimers Dis"},{"issue":"7\u20138","key":"1288_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/1533317519860334","volume":"34","author":"C Rui-Hua","year":"2019","unstructured":"Rui-Hua C, Yong-de P, Xiao-Zhen J, Chen J, Bin Z. Decreased Levels of Serum IGF-1 and Vitamin D Are Associated With Cognitive Impairment in Patients With Type 2 Diabetes. Am J Alzheimers Dis Other Demen. 2019;34(7\u20138):450\u20136.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"12","key":"1288_CR13","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1210\/jc.2012-2063","volume":"97","author":"E Duron","year":"2012","unstructured":"Duron E, Funalot B, Brunel N, Coste J, Quinquis L, Viollet C, Belmin J, Jouanny P, Pasquier F, Treluyer JM, et al. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer\u2019s disease. J Clin Endocrinol Metab. 2012;97(12):4673\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"1288_CR14","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1212\/WNL.0000000000000382","volume":"82","author":"AJ Westwood","year":"2014","unstructured":"Westwood AJ, Beiser A, Decarli C, Harris TB, Chen TC, He XM, Roubenoff R, Pikula A, Au R, Braverman LE, et al. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology. 2014;82(18):1613\u20139.","journal-title":"Neurology"},{"issue":"4","key":"1288_CR15","doi-asserted-by":"publisher","first-page":"e0154450","DOI":"10.1371\/journal.pone.0154450","volume":"11","author":"S Tumati","year":"2016","unstructured":"Tumati S, Burger H, Martens S, van der Schouw YT, Aleman A. Association between Cognition and Serum Insulin-Like Growth Factor-1 in Middle-Aged & Older Men: An 8 Year Follow-Up Study. PLoS One. 2016;11(4):e0154450.","journal-title":"PLoS One"},{"issue":"8","key":"1288_CR16","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/mp.2017.152","volume":"23","author":"OP Almeida","year":"2018","unstructured":"Almeida OP, Hankey GJ, Yeap BB, Paul Chubb SA, Gollege J, Flicker L. Risk of prevalent and incident dementia associated with insulin-like growth factor and insulin-like growth factor-binding protein 3. Mol Psychiatry. 2018;23(8):1825\u20139.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"1288_CR17","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/STROKEAHA.116.016563","volume":"48","author":"H Saber","year":"2017","unstructured":"Saber H, Himali JJ, Beiser AS, Shoamanesh A, Pikula A, Roubenoff R, Romero JR, Kase CS, Vasan RS, Seshadri S. Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke: The Framingham Study. Stroke. 2017;48(7):1760\u20135.","journal-title":"Stroke"},{"issue":"11","key":"1288_CR18","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1210\/jc.2004-2088","volume":"90","author":"SP Johnsen","year":"2005","unstructured":"Johnsen SP, Hundborg HH, S\u00f8rensen HT, Orskov H, Tj\u00f8nneland A, Overvad K, J\u00f8rgensen JO. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab. 2005;90(11):5937\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1288_CR19","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1210\/jc.2006-1631","volume":"92","author":"RC Kaplan","year":"2007","unstructured":"Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab. 2007;92(4):1319\u201325.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1288_CR20","doi-asserted-by":"publisher","first-page":"e0144755","DOI":"10.1371\/journal.pone.0144755","volume":"10","author":"DH Li","year":"2015","unstructured":"Li DH, He YC, Quinn TJ, Liu J. Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Na\u00efve Parkinson\u2019s Disease: A Meta-Analysis. PLoS One. 2015;10(12):e0144755.","journal-title":"PLoS One"},{"issue":"3","key":"1288_CR21","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"11","key":"1288_CR22","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/nn.4393","volume":"19","author":"KL Miller","year":"2016","unstructured":"Miller KL, Alfaro-Almagro F, Bangerter NK, Thomas DL, Yacoub E, Xu JQ, Bartsch AJ, Jbabdi S, Sotiropoulos SN, Andersson JLR, et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci. 2016;19(11):1523\u201336.","journal-title":"Nat Neurosci"},{"issue":"2","key":"1288_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234\u201344.","journal-title":"Int J Epidemiol"},{"key":"1288_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.neuroimage.2017.10.034","volume":"166","author":"F Alfaro-Almagro","year":"2018","unstructured":"Alfaro-Almagro F, Jenkinson M, Bangerter NK, Andersson JLR, Griffanti L, Douaud G, Sotiropoulos SN, Jbabdi S, Hernandez-Fernandez M, Vallee E, et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. Neuroimage. 2018;166:400\u201324.","journal-title":"Neuroimage"},{"key":"1288_CR25","unstructured":"Townsend P PP, Beattie A. Health and deprivation: inequality and the North.\u00a0London: Croom Helm; 1988."},{"issue":"9","key":"1288_CR26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.jalz.2015.06.1885","volume":"11","author":"J Weuve","year":"2015","unstructured":"Weuve J, Proust-Lima C, Power MC, Gross AL, Hofer SM, Thi\u00e9baut R, Ch\u00eane G, Glymour MM, Dufouil C. Guidelines for reporting methodological challenges and evaluating potential bias in dementia research. Alzheimers Dement. 2015;11(9):1098\u2013109.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1288_CR27","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3233\/JAD-200338","volume":"76","author":"AC Ferguson","year":"2020","unstructured":"Ferguson AC, Tank R, Lyall LM, Ward J, Celis-Morales C, Strawbridge R, Ho F, Whelan CD, Gill J, Welsh P, et al. Alzheimer\u2019s Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769). J Alzheimers Dis. 2020;76(4):1541\u201351.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1288_CR28","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3233\/JAD-200374","volume":"77","author":"PJ Smith","year":"2020","unstructured":"Smith PJ, Mabe SM, Sherwood A, Doraiswamy PM, Welsh-Bohmer KA, Burke JR, Kraus WE, Lin PH, Browndyke JN, Babyak MA, et al. Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial. J Alzheimers Dis. 2020;77(4):1793\u2013803.","journal-title":"J Alzheimers Dis"},{"key":"1288_CR29","doi-asserted-by":"crossref","unstructured":"Cho SY, Roh HT. Taekwondo Enhances Cognitive Function as a Result of Increased Neurotrophic Growth Factors in Elderly Women. Int J Environ Res Public Health 2019;16(6):962.","DOI":"10.3390\/ijerph16060962"},{"issue":"3","key":"1288_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/acel.12583","volume":"16","author":"S Tarantini","year":"2017","unstructured":"Tarantini S, Valcarcel-Ares NM, Yabluchanskiy A, Springo Z, Fulop GA, Ashpole N, Gautam T, Giles CB, Wren JD, Sonntag WE, et al. Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype. Aging Cell. 2017;16(3):469\u201379.","journal-title":"Aging Cell"},{"issue":"3","key":"1288_CR31","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s12035-019-01827-y","volume":"57","author":"MC Selles","year":"2020","unstructured":"Selles MC, Fortuna JTS, Zappa-Villar MF, de Faria YPR, Souza AS, Suemoto CK, Leite REP, Rodriguez RD, Grinberg LT, Reggiani PC, et al. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of A\u03b2 Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model. Mol Neurobiol. 2020;57(3):1473\u201383.","journal-title":"Mol Neurobiol"},{"key":"1288_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.exger.2016.11.004","volume":"94","author":"S Tarantini","year":"2017","unstructured":"Tarantini S, Tran CHT, Gordon GR, Ungvari Z, Csiszar A. Impaired neurovascular coupling in aging and Alzheimer\u2019s disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline. Exp Gerontol. 2017;94:52\u20138.","journal-title":"Exp Gerontol"},{"issue":"6","key":"1288_CR33","doi-asserted-by":"publisher","first-page":"e045776","DOI":"10.1136\/bmjopen-2020-045776","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Yang W, Li J, Zhang Y, Zhang L, Chen S, He L, Zhang Y. Relationship between serum insulin-like growth factor 1 levels and ischaemic stroke: a systematic review and meta-analysis. BMJ Open. 2022;12(6):e045776.","journal-title":"BMJ Open"},{"issue":"1","key":"1288_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12967-020-02223-0","volume":"18","author":"I Castilla-Cort\u00e1zar","year":"2020","unstructured":"Castilla-Cort\u00e1zar I, Aguirre GA, Femat-Rold\u00e1n G, Mart\u00edn-Estal I, Espinosa L. Is insulin-like growth factor-1 involved in Parkinson\u2019s disease development? J Transl Med. 2020;18(1):70.","journal-title":"J Transl Med"},{"issue":"2","key":"1288_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1179\/016164104225013851","volume":"26","author":"ED Rabinovsky","year":"2004","unstructured":"Rabinovsky ED. The multifunctional role of IGF-1 in peripheral nerve regeneration. Neurol Res. 2004;26(2):204\u201310.","journal-title":"Neurol Res"},{"issue":"1","key":"1288_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-220356","volume":"88","author":"K Wittfeld","year":"2022","unstructured":"Wittfeld K, Raman MR, Conner SC, Aslam A, Teumer A, Nauck M, Hosten N, Habes M, DeCarli C, Vasan RS, et al. Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer\u2019s Disease in Predominantly Middle-Aged Adults. J Alzheimers Dis. 2022;88(1):311\u201322.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1288_CR37","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1210\/clinem\/dgab121","volume":"106","author":"A Salzmann","year":"2021","unstructured":"Salzmann A, James SN, Williams DM, Richards M, Cadar D, Schott JM, Coath W, Sudre CH, Chaturvedi N, Garfield V. Investigating the Relationship Between IGF-I, IGF-II, and IGFBP-3 Concentrations and Later-Life Cognition and Brain Volume. J Clin Endocrinol Metab. 2021;106(6):1617\u201329.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1288_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrendo.2013.64","volume":"9","author":"DE Berryman","year":"2013","unstructured":"Berryman DE, Glad CA, List EO, Johannsson G. The GH\/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol. 2013;9(6):346\u201356.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1288_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","volume":"150","author":"R Clarke","year":"1999","unstructured":"Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341\u201353.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1288_CR40","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1210\/er.2001-0033","volume":"23","author":"SM Firth","year":"2002","unstructured":"Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002;23(6):824\u201354.","journal-title":"Endocr Rev"},{"key":"1288_CR41","doi-asserted-by":"crossref","unstructured":"Batty GD, Gale CR, Kivimaki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ 2020;368:m131.","DOI":"10.1136\/bmj.m131"},{"issue":"9","key":"1288_CR42","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, Collins R, Allen NE. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186(9):1026\u201334.","journal-title":"Am J Epidemiol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01288-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-023-01288-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01288-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T09:07:06Z","timestamp":1700471226000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-023-01288-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1186\/s13195-023-01288-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"19 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave informed consent for data provision and linkage. UK Biobank has full ethical approval from the NHS National Research Ethics Service (16\/NW\/0274).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}